文献速递糖尿病肥胖与代谢综合征

肥胖与糖尿病和SARS-CoV-2感染及症状的关联:COVID-19社区研究伙伴关系

Association of Obesity and Diabetes with SARS-Cov-2 Infection and Symptoms in the COVID-19 Community Research Partnership.
PubMed 文献 · J Clin Endocrinol Metab · 2022-12-09

该研究纳入44,430名COVID-19社区研究伙伴关系参与者,评估自报及电子健康记录的肥胖和糖尿病与自报COVID-19阳性检测的关联;在2,663名自报阳性参与者中评估与症状严重程度、持续时间及住院的关联。结果显示BMI类别与阳性检测呈正向梯度关联,糖尿病与感染相关但校正后与症状无关,肥胖与糖尿病间可能存在交互作用。

要点

  • BMI类别与自报COVID-19阳性检测呈正向梯度关联,超重OR=1.14,肥胖I OR=1.29,肥胖II OR=1.34,肥胖III OR=1.53。
  • 在阳性检测者中,肥胖与糖尿病与症状严重程度呈相似但较弱的关联。
  • 糖尿病与COVID-19感染相关,但校正后与症状无关,肥胖与糖尿病间存在一定交互作用证据。

核心结论

  • BMI与糖尿病和自报COVID-19感染存在强梯度关联,提示肥胖和糖尿病可能参与症状性SARS-CoV-2感染风险,超越社会经济因素的共现。

研究设计与样本

  • 在44,430名COVID-19社区研究伙伴关系参与者中,评估自报和电子健康记录的肥胖与糖尿病和自报COVID-19阳性检测的关联。
  • 在2,663名研究期间自报COVID-19阳性检测的参与者中,评估肥胖和糖尿病与自报症状严重程度、持续时间及住院的关联。
  • 采用逻辑回归模型,校正年龄、性别、种族/民族、社会经济状况和医护人员身份。

主要发现

  • 在阳性检测者中,肥胖和糖尿病与COVID-19症状及严重程度呈相似但较弱的关联。
  • 糖尿病与COVID-19感染相关,但校正后与症状无关,肥胖与糖尿病间存在一定交互作用证据。

局限性

  • 该健康系统便利样本的局限性包括普遍性受限和围绕检测寻求的选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Obesity and diabetes are established risk factors for severe SARS-CoV-2 outcomes, but less is known about their impact on susceptibility to COVID-19 infection and general symptom severity. We hypothesized that those with obesity or diabetes would be more likely to self-report a positive SARS-CoV-2 test, and among those with a positive test, have greater symptom severity and duration. METHODS: Among 44,430 COVID-19 Community Research Partnership participants, we evaluated the association of self-reported and electronic health record obesity and diabetes with a self-reported positive COVID-19 test at any time. Among the 2,663 participants with a self-reported positive COVID-19 test during the study, we evaluated the association of obesity and diabetes with self-report of symptom severity, duration, and hospitalization. Logistic regression models were adjusted for age, sex, race/ethnicity, socioeconomic status, and healthcare worker status. RESULTS: We found a positive graded association between Body Mass Index (BMI) category and positive COVID-19 test (Overweight OR = 1.14 [1.05-1.25]; Obesity I OR = 1.29 [1.17-2.42]; Obesity II OR = 1.34 [1.19-1.50]; Obesity III OR = 1.53 [1.35-1.73]), and a similar but weaker association with COVID-19 symptoms and severity among those with a positive test. Diabetes was associated with COVID-19 infection but not symptoms after adjustment, with some evidence of an interaction between obesity and diabetes. CONCLUSIONS: While the limitations of this health system convenience sample include generalizability and selection around test-seeking, the strong graded association of BMI and diabetes with self-reported COVID-19 infection suggests that obesity and diabetes may play a role in risk for symptomatic SARS-CoV-2 beyond co-occurrence with socioeconomic factors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mongraw-Chaffin M, Tjaden AH, Seals AL, et al. Association of Obesity and Diabetes with SARS-Cov-2 Infection and Symptoms in the COVID-19 Community Research Partnership. J Clin Endocrinol Metab. 2022. PMID: 36482096. doi:10.1210/clinem/dgac715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。